Protagenic Therapeutics, Inc.
PTIX
$0.49
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.73% | -33.54% | -- | ||
| Total Receivables | -5.68% | -55.38% | -- | ||
| Inventory | 0.00% | 0.00% | -- | ||
| Prepaid Expenses | -51.66% | -32.94% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -19.56% | -34.01% | -- | ||
|
|
|||||
| Total Current Assets | -19.56% | -34.01% | -- | ||
| Net Property, Plant & Equipment | -24.51% | -19.69% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 0.00% | 0.00% | -- | ||
| Total Assets | -11.43% | -22.89% | -- | ||
|
|
|||||
| Total Accounts Payable | 23.69% | -21.22% | -- | ||
| Total Accrued Expenses | -38.01% | -19.34% | -- | ||
| Short-term Debt | -0.03% | -0.38% | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -85.11% | -5.27% | -- | ||
| Total Other Current Liabilities | -85.11% | -5.27% | -- | ||
| Total Current Liabilities | -29.68% | -7.25% | -- | ||
|
|
|||||
| Total Current Liabilities | -29.68% | -7.25% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -0.03% | -0.38% | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -29.68% | -7.25% | -- | ||
|
|
|||||
| Common Stock & APIC | 1.40% | 1.57% | -- | ||
| Retained Earnings | 19.52% | -8.32% | -- | ||
| Treasury Stock & Other | 0.54% | 14.33% | -- | ||
| Total Common Equity | 49.10% | -18.28% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 49.10% | -18.28% | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 49.10% | -18.28% | -- | ||
|
|
|||||